Publications by authors named "Sandeep R Pandey"

Article Synopsis
  • Buerger's disease (BD) is a serious condition that requires early diagnosis for effective treatment, but there’s no universally accepted method for diagnosing it due to varied criteria used by different vascular centers.
  • A recent Delphi Consensus Study highlighted the lack of consensus on BD diagnostic criteria, particularly beyond the requirement of a history of smoking, making it hard to compare patient outcomes globally.
  • The VAS-European Independent Foundation has proposed that a definitive BD diagnosis should include a history of smoking, typical angiographic and histopathological features, and suggests using a combination of major and minor criteria for suspected diagnoses, with validation studies currently in progress.
View Article and Find Full Text PDF

This position paper, written by members of International Union of Angiology (IUA) Youth Committee, shows an overview of coagulation system and laboratory tests, analysis of medical therapies (older and newer), medication discontinuation/restart recommendations, bridging therapy recommendations, and an overview of hemostatic agents used in the operating room.

View Article and Find Full Text PDF
Article Synopsis
  • Buerger's disease (BD) is challenging to diagnose due to a lack of universally accepted criteria, making proper identification difficult.
  • A modified Delphi consensus study involving 29 experts sought to establish a more definitive set of diagnostic criteria for BD, ultimately leading to the acceptance of several key factors such as a history of tobacco use and certain physical symptoms.
  • The study highlighted significant discrepancies in existing diagnostic criteria and emphasized the need for a standardized approach to diagnosing BD in clinical settings.
View Article and Find Full Text PDF

Even today thromboangiitis obliterans has disease features that remain misunderstood or underappreciated. The epidemiology, etiology and pathophysiology of the disease are still unclear. Biomarkers and disease activity markers are lacking, thus clinical assessment is difficult.

View Article and Find Full Text PDF